Navigation Links
Theodore A. Boutacoff Appointed President & CEO of IRIDEX
Date:10/17/2007

MOUNTAIN VIEW, Calif., Oct. 17 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq: IRIX) announced today that Barry Caldwell has resigned as the Company's President and Chief Executive Officer, and as a member of the Board of Directors, effective as of October 16, 2007. The Board of Directors has appointed Theodore A. Boutacoff, who is currently a member and Chairman of the Board of Directors, to serve as the Company's President and Chief Executive Officer. Prior to Mr. Caldwell's two year tenure, Mr. Boutacoff had been the Company's President and Chief Executive Officer since co-founding the Company in 1989.

"Barry has worked hard during his tenure at IRIDEX," Mr. Boutacoff commented, "We wish him the best of success in his future endeavors."

About IRIDEX

IRIDEX Corporation is a leading worldwide provider of therapeutic based laser systems, disposable laser probes and delivery devices to treat eye diseases in ophthalmology and skin disorders in the aesthetics market. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 97 independent distributors into 107 countries.


'/>"/>
SOURCE IRIDEX Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Wood Appointed As the First Chair of SAADAT
2. Yoga Guru appointed Bihars brand ambassador
3. Disappointed Students Plan To Intensify Agitation Nationwide
4. City Surgeon Appointed Adviser To Armed Forces
5. Indian-American Appointed for US Hospital Top Post
6. Retiring Government Doctors to Be Reappointed to Overcome Paucity of Specialists
7. Clintons new problem - Is the outgoing American president suffering from skin cancer?
8. Past President Narayanans Condition Still Critical
9. President and Founder of National Obesity Forum Resigns
10. President Bush Urges Citizens to Invest In Health Savings Account (HSAs)
11. President Bush proposes HSAs scheme for the benefit of both the workers and the country
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... ... According to an article published February 4th on mySA, robotically ... hernia repairs throughout the United States. Commenting on this article, Beverly Hills hernia repair ... has not only been expected, but it seems to be a natural result of ...
(Date:2/12/2016)... ... ... Enforcement Trends: , Back to the Future , Feb. 25, 2016 — 11:00 a.m. – ... who don’t learn from history are doomed to repeat it.” , An analysis of CDRH’s ... But that takes time. , Take a close look at the warning letters the ...
(Date:2/12/2016)... ... February 12, 2016 , ... T.E.N., ... have closed for the ISE Southeast Awards 2016. Finalists and winners of the ... ISE® Southeast Executive Forum and Awards Gala on March 15, 2016 at the ...
(Date:2/12/2016)... ... 12, 2016 , ... AssureVest Insurance Group, a locally owned insurance firm with ... will raise funds earmarked to purchase computers and software for Mrs. Harrison’s 2nd and ... is in a low-income area and has more than 60 2nd and 3rd graders ...
(Date:2/12/2016)... ... February 12, 2016 , ... Donor Network West, the organ procurement organization that ... partnership with San Ramon Regional Medical Center. Under the collaboration, the first of its ... to accommodate a more certain time frame for donor families for the recovery of ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... 12, 2016  SI-BONE, Inc., a medical device company that pioneered ... minimally invasive surgical (MIS) device indicated for fusion for certain disorders ... (NGS), the Medicare Administrative Contractor (MAC) covering the states of ... Maine , Massachusetts , Minnesota ... York , Rhode Island , ...
(Date:2/12/2016)... SAN DIEGO and SEOUL, ... -- Silicon Biosys­tems Menarini and Macrogen, Inc. today ... clinical assays and innovative procedures for precision medicine ... to combine Silicon Biosystems, DEPArray™ digital-sorting technology with ... development of tests certified under the Clinical Laboratory ...
(Date:2/12/2016)... , Feb. 12, 2016  Apellis Pharmaceuticals, ... a $47.1 million Series D preferred stock ... Management, Hillhouse Capital Group and venBio Global ... Investments, AJU IB Investment, and Epidarex Capital. The ... to further advance clinical trials in the ...
Breaking Medicine Technology: